Table 3.
OS | Multivariate analysis 1 | Multivariate analysis 2 | ||
HR (95% CI) | P value | HR (95% CI) | P value | |
Sex | ||||
Female vs male | 0.87 (0.46–1.63) | P = 0.66 | 0.75 (0.39–1.42) | P = 0.37 |
Age | ||||
< 69 vs ≥ 69 | 0.78 (0.40–1.50) | P = 0.45 | 1.41 (0.65–3.06) | P = 0.39 |
Lymph node metastasis | ||||
Yes vs no | 1.42 (0.82–2.46) | P = 0.22 | 1.66 (0.93–2.95) | P = 0.084 |
cIS1 | ||||
High vs low | 0.34 (0.17–0.67) | P = 0.002 | ||
cIS2 | ||||
High vs low | 0.14 (0.06–0.32) | P < 0.001 | ||
PFS | Multivariate analysis 1 | Multivariate analysis 2 | ||
Sex | ||||
Female vs male | 0.68 (0.28–1.65) | P = 0.40 | 0.51 (0.20–1.28) | P = 0.15 |
Age | ||||
< 69 vs ≥ 69 | 0.68 (0.30–1.46) | P = 0.31 | 1.38 (0.52–3.66) | P = 0.52 |
Lymph node metastasis | ||||
Yes vs no | 2.03 (0.98–4.22) | P = 0.056 | 2.67 (1.26–5.68) | P = 0.10 |
cIS1 | ||||
High vs low | 0.41 (0.19–0.86) | P = 0.019 | ||
cIS2 | ||||
High vs low | 0.16 (0.06–0.4) | P < 0.001 |
The bold value indicates P < 0.05, HR Hazard ratio, CI Confidence interval, sex, age, lymph node metastasis, and cIS1 were included in multivariate analysis 1; sex, age, lymph node metastasis and cIS2 were included in multivariate analysis 2